2 Excessive Dips Provide A Very Good Buying Opportunity: GW Pharmaceuticals

2 Excessive Dips Provide A Very Good Buying Opportunity: GW Pharmaceuticals

GW Pharmaceuticals (GWPH), a biopharmaceutical company that makes its money selling Epidiolex (cannabidiol) for seizures associated with select diseases, is currently down over 55% from highs in May 2019. While the market-wide sell-off due to coronavirus acco…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *